-+ 0.00%
-+ 0.00%
-+ 0.00%

ESTRELLA IMMUNOPHARMA COMPLETES FIRST DOSE COHORT IN STARLIGHT-1 TRIAL AND RECEIVES APPROVAL TO INITIATE HIGHER DOSE COHORT

Reuters·02/21/2025 13:30:38

Please log in to view news